FDAClass IIIJanuary 6, 2021

Neostigmine Methylsulfate PF Inj. 5 mg/5 mL recall: Labeling Error

Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800)…

Why was Neostigmine Methylsulfate PF Inj. 5 mg/5 mL recalled?

Labelling: Missing label.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 20202109@3 BUD: 3/20/2021

Product
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800)…
Recalling firm
US Compounding Inc
Quantity
1640 syringes
Distribution
Nationwide
Recall date
January 6, 2021
Classification
Class III
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls